Covera Health Enhances its Radiology Center of Excellence Program with Mammography AI for Breast Cancer Detection
Summary
NEW YORK--(BUSINESS WIRE)--Covera Health, the country’s leading provider of clinical analytics solutions to reduce medical misdiagnoses and improve healthcare quality, announced the integration of ScreenPoint Medical’s artificial intelligence (AI) tools into its quality analytics platform. The platform we’ve built connecting providers and payers allows for these quality-improving tools to reach millions of patients, virtually overnight," explained Vianu further. Richard Herzog, MD, FACR, Covera’s Chief Medical Officer noted that “Were excited to be able to deliver continued value to our physician partners across the country, which has the potential to save millions of lives through earlier detection of breast cancers.” ScreenPoint Medical’s FDA-approved Transpara® tool is the world’s first dedicated AI decision support solution for 2D and 3D mammography. Its analytics and quality insights reduce the prevalence and impact of medical misdiagnosis, a leading cause of patient harm, inappropriate care, and unnecessary cost. ScreenPoint Medical is the leading developer of AI-driven image analysis technology which enables the automated reading of mammograms and digital breast tomosynthesis examinations.